Last updated on April 2018

A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA Safety and PK


Brief description of study

A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial of LCB01-0371.

Detailed Study Description

This study is designed to explore antituberculosis of LCB01-0371 through the assess of the early bactericidal activity, safety of administration.

Clinical Study Identifier: NCT02836483

Contact Investigators or Research Sites near you

Start Over

T.S. Sim, M.D., Ph.D

Asan Medical Center
Seoul, Korea, Republic of
2.06miles
  Connect »